RyanEllisMD Profile Banner
Ryan Ellis Profile
Ryan Ellis

@RyanEllisMD

Followers
473
Following
378
Media
3
Statuses
66

Surgical Oncologist and HPB Surgeon @IU_Health | Health services researcher focused on access to cancer care and pragmatic clinical trials | Tweets are my own

Indianapolis, IN
Joined July 2017
Don't wanna be here? Send us removal request.
@RyanEllisMD
Ryan Ellis
5 months
Had a great time! Thanks @HalletJulie and @PatricioPolanc0 for the invite and expert podcast guidance!
@HalletJulie
Julie Hallet
5 months
🚨 #AHPBA2025 recap🎙️ Missed the meeting? Spent time at the beach🏖️? Too many sessions to pick from? Get your update in 🆕 #SurgOncToday with @RyanEllisMD & @michael_lidsky: HAIP⛽️, locally advanced PDAC, PNETs, NSQIP & more! 🔗 https://t.co/NZCr1laGKi
Tweet media one
0
0
7
@HalletJulie
Julie Hallet
6 months
With #AHPBA2025 & #SSO2025 back to back, we had a chance to recap AHPBA during live #SurgOncToday podcast 🎙️recording in Tampa Bay🌴 Thanks @michael_lidsky and @RyanEllisMD for reviewing top studies presented in Miami! HAIP, pancreas cancer, POPF, ablation & more. Stay tuned!🎧
Tweet media one
Tweet media two
Tweet media three
0
8
34
@QaisAbuHasan
Qais AbuHasan
7 months
Our @kristen_kaiser1 crushed another talk this morning on the use of large language models (LLMs) in clinical decision support at #ASC2025 @AcademicSurgery @IU_SOQIC @IU_Surgery @RyanEllisMD @kbilimoria
Tweet media one
0
4
16
@RyanEllisMD
Ryan Ellis
7 months
Second year @IU_SOQIC research resident @JacksonBaril presenting work on the impact of surgeon-scrub tech familiarity on operative time and costs. Great job representing @IU_Surgery in the #ASC2025 Clinical Outcomes Plenary session!
Tweet media one
1
8
31
@HalletJulie
Julie Hallet
10 months
Get ready for your 2024 HPB Wrapped!🎁 🎙️ Coming in December! #SurgOncToday podcast will cover the🔝 10 studies in HPB surgical oncology 🔹Vaccine therapy 🔹Neoadjuvant for PDAC 🔹Adjuvant for IPMN 🔹TXA 🔹PRRT for PNETs 🔹Drains! 🔹MRI for CRLM 🔹Transplant for CRLM & more!
Tweet media one
0
11
32
@PaulKaranicolas
Paul Karanicolas
1 year
Thanks to all the amazing patients, surgeons, and researchers who made this trial possible. TXA did not reduce bleeding or blood transfusion but increased periop complications after liver resection. ⁦@JAMA_current
Tweet card summary image
jamanetwork.com
This randomized clinical trial assesses the effect of tranexamic acid vs placebo on the need for blood transfusion among patients undergoing cancer-related liver resection.
11
28
100
@kbilimoria
Karl Bilimoria
1 year
Year 13 of the annual SOQIC BBQ for our research team! Beautiful day and loved seeing everyone together. Great fun to have some of the Chicago folks come down and hang with our Indy team. (Always forget to take enough pics) @IU_Surgery @IU_SOQIC @Regenstrief
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
9
34
@IU_Surgery
Indiana Surgery -Indiana Univ School of Medicine
1 year
⭐️Coming Soon to IU Surgery and @IU_SOQIC in October! Help us welcome: ➡️Cary Schlick, MD, MS (@CarySchlick) 👩⚕️ Dr. Schlick comes to us from @MSKCancerCenter 🏥Dr. Schlick is a health services and outcomes researcher with areas of focus in optimizing healthcare delivery
Tweet media one
0
8
34
@SigneBraafladt
Signe Braafladt MD
1 year
Great presentation by Dr @JacksonBaril on the rate of upstaging of clinical T2N0 gastric cancer and the implications on treatment sequencing. Engaging discussion on how to interpret and apply these findings at #CSA2024 @IU_Surgery @IU_SOQIC @RyanEllisMD
Tweet media one
Tweet media two
0
6
12
@AnnSurgOncol
Annals of Surgical Oncology
2 years
Tweet media one
0
4
17
@michael_lidsky
Michael Lidsky, MD, FACS
2 years
Herculean effort by so many to get this important + very timely trial activated. #EA2222 will answer a critical question for oncologists, and most importantly for patients. #HAI #HAIconsortium @eaonc @NCICTEP_ClinRes @colontown @FightCRC @MichaelDAngeli2 @AndreaCercek @skmaithel
@eaonc
ECOG-ACRIN Cancer Research Group
2 years
Trial Activation: EA2222/PUMP, led by @michael_lidsky of @DukeSurgOnc and @DukeCancer, is a randomized phase III study of #systemictherapy with or without hepatic arterial infusion for unresectable #colorectal liver metastases. For more info: https://t.co/xBChV6GALe #ColonCancer
Tweet media one
7
10
58
@SocSurgOnc
Society of Surgical Oncology
2 years
Join Surgical Oncology experts on October 16 as they discuss and provide their insights on unique and challenging Hepato-Pancreato-Biliary (HPB) cases. Register Now: https://t.co/obnRG7P00Q
Tweet media one
0
17
37
@RyanEllisMD
Ryan Ellis
2 years
Threw my hat into the ring for the @AcademicSurgery Clinical and Health Services Committee! The AAS has been key to my own development, and I’d be thrilled to contribute to the continued growth of the organization. Would appreciate your vote! #ElectMyAAS https://t.co/vFGzLsDQrz
aasurg.org
1
11
27
@kbilimoria
Karl Bilimoria
2 years
You know you made a good choice when the Vice President of the ⁦@AmBdSurg (⁩@jmellinger58⁩) calls out the work of our new faculty member in his talk & uses HER slides - and it’s only her 3rd day as faculty! Glad you are here, ⁦@AmyHolmstromMD⁩! ⁦@IU_Surgery
Tweet media one
0
4
32
@IU_Surgery
Indiana Surgery -Indiana Univ School of Medicine
2 years
Welcome to IU Surgery, Amy Holmstrom, MD! [@AmyHolmstromMD] Quick facts: 👉FEL: @WeillCornell 👉Assistant Professor of Clinical Surgery in General Surgery focused on MIS 👉Research Focus: Surgical education with a focus on autonomy and assessment Learn more:
Tweet media one
0
3
23
@RyanEllisMD
Ryan Ellis
2 years
August 1st means it’s official! So grateful to have spent my final year of surgical oncology training with this brilliant group of co-fellows and the world-class @MSKCancerCenter faculty. Excited to join faculty @IU_Surgery next month. But first…vacation!
Tweet media one
Tweet media two
Tweet media three
3
1
55
@RyanEllisMD
Ryan Ellis
2 years
Excited to see the first ever @AmCollSurgeons NSQIP-linked RCT published today! Significant reduction in post-Whipple SSI with change in periop antibiotics Large, multi-center surgery trial performed without formal funding! @MichaelDAngeli2 @cliffordkomd @AHPBA @MSKCancerCenter
@JAMA_current
JAMA
2 years
Study findings support the use of piperacillin-tazobactam as perioperative antimicrobial prophylaxis for open pancreatoduodenectomy. https://t.co/vI0fBMTas5
Tweet media one
1
17
93
@AnnalsofSurgery
Annals of Surgery
2 years
Association between Biliary Pathogens, Surgical Site Infection, and Pancreatic Fistula: Results of a Randomized Trial of Perioperative Antibiotic Prophylaxis in Patients Undergoing Pancreatoduodenectomy @ryanellismd @MSKCancerCenter @Bbrajcich @NMSurgery @NU_SOQIC #AmerSurg23
Tweet media one
0
13
37
@AmyHolmstromMD
Amy Holmstrom
2 years
Tweet media one
0
5
29